Abstract
Aims
Percutaneous left atrial appendage occlusion (LAAo) is commonly performed under fluoroscopy including the use of contrast dye. In this study, we aimed to assess feasibility and safety of contrast-free, 3D-echo-based LAAo with the use of the AMPLATZER™ Amulet™ device.
Methods and results
We analyzed 20 patients (74 ± 10 years, 65% males) at an increased thromboembolic and bleeding risk (CHA2DS2VASC 4.0 ± 1.3; HAS-BLED 3.5 ± 0.9) with chronic renal failure (GFR 41 ± 21 ml/min) undergoing LAAo without the use of contrast dye at our center and compared the results with a propensity-matched cohort (1:1 matching) of conventionally treated patients receiving contrast agent. Contrast-free LAAo was associated with less radiation exposure (13.1 ± 19.2 vs. 32.9 ± 21.2 Gy*cm2, p < 0.01) and fluoroscopy time (5.0 ± 3.4 vs. 11.6 ± 4.9 min, p < 0.01). Procedural success rates were excellent in both groups (100%) without severe periprocedural complications (i.e. procedural death, stroke/systemic embolism, myocardial infarction, cardiac tamponade or major bleeding).
Conclusions
Echocardiographically guided LAAo without the use of contrast dye appears safe and feasible. This approach appears to be associated with reduced radiation exposure and may represent an alternative to traditional LAAo, especially in patients in whom the avoidance of contrast dye is warranted.
Abbreviations
- BMI:
-
Body mass index
- CHA2DS2VASC:
-
CHA2DS2VASC-score
- CT:
-
Computed tomography
- Dmax/Dmin:
-
Maximal/minimal diameter (of the LAA ostium)
- DRT:
-
Device-related thrombus
- HAS-BLED:
-
HAS-BLED-score
- GFR:
-
Glomerular filtration rate
- LAA:
-
Left atrial appendage
- LAAo:
-
Left atrial appendage occlusion
- LVEF:
-
Left ventricular ejection fraction
- MAE:
-
Major adverse event
- TEE:
-
Transesophageal echocardiography
- VARC:
-
Valve academic research consortium
References
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, PROTECT AF Investigators (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534–542
Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY (2014) Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 64:1–12
Seeger J, Bothner C, Dahme T, Gonska B, Scharnbeck D, Markovic S, Rottbauer W, Wöhrle J (2016) Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clin Res Cardiol 105:225–229 (Springer, Berlin)
Rajwani A, Nelson AJ, Shirazi MG, Disney PJS, Teo KSL, Wong DTL, Young GD, Worthley SG (2016) CT sizing for left atrial appendage closure is associated with favourable outcomes for procedural safety. Eur Heart J Cardiovasc Imaging 18:jew212–jew218
Kottmaier M, Jilek C, Berglar S et al (2018) Exclusion of left atrial thrombus by dual-source cardiac computed tomography prior to catheter ablation for atrial fibrillation. Clin Res Cardiol 20:e1–e7 (Springer, Berlin Heidelberg)
Ternacle J, Lellouche N, Deux J-F, Dubois-Randé J-L, Teiger E, Lim P (2015) Left atrial appendage closure monitoring without sedation: a pilot study using intracardiac echocardiography through the oesophageal route. EuroIntervention 11:936–941
Hell MM, Achenbach S, Yoo IS, Franke J, Blachutzik F, Roether J, Graf V, Raaz-Schrauder D, Marwan M, Schlundt C (2017) 3D printing for sizing left atrial appendage closure device: head-to-head comparison with computed tomography and transesophageal echocardiography. EuroIntervention 13:1234–1241
Andreis A, Budano C, Levis M et al. (2017) Contrast-induced kidney injury: how does it affect long-term cardiac mortality? J Cardiovasc Med (Hagerstown) 18:908–915
Kappetein AP, Head SJ, Généreux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60:1438–1454
Tzikas A, Holmes DR, Gafoor S et al (2016) Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies. EuroIntervention 12:103–111
Viles-Gonzalez JF, Kar S, Douglas P, Dukkipati S, Feldman T, Horton R, Holmes D, Reddy VY (2012) The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation) substudy. J Am Coll Cardiol 59:923–929
Wunderlich NC, Beigel R, Swaans MJ, Ho SY, Siegel RJ (2015) Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography. JACC: Cardiovasc Imaging 8:472–488
Al-Kassou B, Tzikas A, Stock F, Neikes F, Völz A, Omran H (2017) A comparison of two-dimensional and real-time 3D transoesophageal echocardiography and angiography for assessing the left atrial appendage anatomy for sizing a left atrial appendage occlusion system: impact of volume loading. EuroIntervention 12:2083–2091
Tzikas A, Shakir S, Gafoor S et al (2016) Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 11:1170–1179
Aminian A, Lempereur M, Ben Yedder M, Dubois P (2018) Real-time fusion of echocardiography and fluoroscopy allowing successful implantation of a WATCHMAN device without contrast injection. EuroIntervention 14(2):174–175. https://doi.org/10.4244/EIJ-D-17-00398
El-Sayed T, Patel AS, Cho JS, Kelly JA, Ludwinski FE, Saha P, Lyons OT, Smith A, Modarai B (2017) Guy’s and St Thomas’ Cardiovascular Research Collaborative: radiation-induced DNA damage in operators performing endovascular aortic repair. Circulation 136:2406–2416
Jungen C, Zeus T, Balzer J, Eickholt C, Petersen M, Kehmeier E, Veulemans V, Kelm M, Willems S, Meyer C (2015) Left atrial appendage closure guided by integrated echocardiography and fluoroscopy imaging reduces radiation exposure. PLoS One 10:e0140386–e0140313 (Andò G ed)
Rillig A, Bellmann B, Skurk C et al (2018) Left atrial appendage angiography is associated with the incidence and number of magnetic resonance imaging-detected brain lesions after percutaneous catheter-based left atrial appendage closure. Heart Rhythm 15:3–8
Fastner C, Behnes M, Henzler T, Borggrefe M, Akin I (2018) Lack of silent cerebral ischemic events: a case series of patients after left atrial appendage closure. Clin Res Cardiol 107:91–93 (Springer, Berlin, Heidelberg)
Ruf TF, Heidrich FM, Sveric KM, Pfluecke C, Stephan A-M, Strasser RH, Wiedemann S (2017) ELMSTREET (Esophageal Lesions during MitraClip® uSing TRansEsophagelEchocardiography-Trial). EuroIntervention 13(12):e1444–e1451. https://doi.org/10.4244/EIJ-D-17-00125
Viehmann M, Dähnert I, Schuler G, Sandri M (2016) Percutaneous closure of an incomplete left atrial appendage closure. Clin Res Cardiol 105:791–793 (Springer, Berlin, Heidelberg)
Main ML, Fan D, Reddy VY et al (2016) Assessment of device-related thrombus and associated clinical outcomes with the WATCHMAN left atrial appendage closure device for embolic protection in patients with atrial fibrillation (from the PROTECT-AF Trial). Am J Cardiol [Internet] 117:1127–1134
Acknowledgements
We would like to thank GE for providing material support to this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
AS, BAK and RS have received travel grants from St. Jude Medical/Abbott. GN has received speaker honoraria from St. Jude Medical/Abbott. HO is a consultant and proctor for St. Jude Medical/Abbott. All other authors report no conflict of interest.
Rights and permissions
About this article
Cite this article
Sedaghat, A., Al-Kassou, B., Vij, V. et al. Contrast-free, echocardiography-guided left atrial appendage occlusion (LAAo): a propensity-matched comparison with conventional LAAo using the AMPLATZER™ Amulet™ device. Clin Res Cardiol 108, 333–340 (2019). https://doi.org/10.1007/s00392-018-1401-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-018-1401-5